Malcolm Boyce
Hammersmith Medicines Research(GB)Trio Medicines (United Kingdom)(GB)
Publications by Year
Research Areas
Helicobacter pylori-related gastroenterology studies, Neuroendocrine Tumor Research Advances, Asthma and respiratory diseases, Gastroesophageal reflux and treatments, Respiratory and Cough-Related Research
Most-Cited Works
- → Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response(2000)385 cited
- → Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate(2017)203 cited
- → Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial(2020)165 cited
- → Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A(2012)108 cited
- → The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography(1996)85 cited
- → Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects